Trials / Completed
CompletedNCT06199596
Alpha-s1 Casein Hydrolysate on Sleep
The Effect of Alpha-s1 Casein Hydrolysate for Patients With Chronic Insomnia: A Randomized Double-Blind Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Kuang Tien General Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the impact of Aalpha-s1 casein hydrolysate (ACH; Lactium®) on sleep quality in individuals with chronic insomnia, employing both subjective sleep profiles and objective polysomnography (PSG) recordings.
Detailed description
During the trial, the use of food or health products containing sedative or hypnotic ingredients or formulations is prohibited.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | alpha-s1 casein hydrolysate | 150mg of Prelactium per capsule |
| DIETARY_SUPPLEMENT | Maltodextrin | 150mg of Maltodextrin per capsule |
Timeline
- Start date
- 2019-05-01
- Primary completion
- 2023-11-30
- Completion
- 2023-11-30
- First posted
- 2024-01-10
- Last updated
- 2024-01-10
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06199596. Inclusion in this directory is not an endorsement.